TrialOpen forum infectious diseases2026

Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

Essack Mitha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.